Pulmonary hypertension in HIV-infected patients;Hypertension artérielle pulmonaire et infection à VIH

Revue des Maladies Respiratoires

Volumn 18, Issue 4 I, 2001, Pages 432-435

  Leautez S ^a   Boutoille, D ^a   Renard, B ^a   Esnault, J L ^a   Raffi, F ^a  

^a HÔTEL DIEU   (France)

Author keywords

AIDS; Hepatitis C; HIV; Intravenous drug user; Pulmonary hypertension

Indexed keywords

ANTICOAGULANT AGENT; ANTIRETROVIRUS AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; PROSTACYCLIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE ACTIVITY; DISEASE COURSE; DYSPNEA; HEART RIGHT VENTRICLE FAILURE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MORTALITY; PROGNOSIS; PULMONARY HYPERTENSION; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIHYPERTENSIVE AGENTS; EPOPROSTENOL; HEPATITIS C; HIV SEROPOSITIVITY; HUMANS; HYPERTENSION, PULMONARY; MALE; PROGNOSIS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0035680982     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Human immunodeficiency virus infection and pulmonary hypertension: Two new cases and a review of 86 reported cases
2. Primary pulmonary hypertension associated with human immunodeficiency virus infection
3. Hypertension artérielle pulmonaire chez le toxicomane VIH+
4. Hypertension artérielle pulmonaire primitive: Un mode rare de révélation du sida. A propos d'une observation
5. HIV-associated primary pulmonary hypertension. A case control study
6. Role of human immunodeficiency virus in primary pulmonary hypertension
7. Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension
8. Platelet-derived growth factor expression in primary pulmonary hypertension: Comparison of HIV seropositive and HIV seronegative patients
9. Pulmonary hypertension associated with human immunodeficiency virus infection. Report of two cases and review of the literature
10. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension
11. Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmoanry hypertension
12. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension